UPDATE: A’s also in the mix for Hisashi Iwakuma, Rangers may have bid too low

1 Comment

2:04 PM: More intrigue from Rosenthal. He tells us that the Athletics also submitted a bid for Iwakuma and that the Rangers’ bid may have actually been too low. According to Rosenthal, the A’s would like to add Iwakuma in order to acquire a hitter from their surplus of starting pitching.

1:15 PM: According to Ken Rosenthal of FOXSports.com, the Rangers may have the highest bid for Japanese right-hander Hisashi Iwakuma. Last night, a Japanese media report suggested that the Mariners were the front-runners.

While we still have no official word about who has the highest bid, Rosenthal confirms that the Rangers did indeed make a bid and writes that it’s possible other AL West clubs are involved. Stay tuned.

10:21 AM: Still no confirmation that the Mariners actually have the highest bid for Iwakuma, but Larry Stone of the Seattle Times tells us that the Golden Eagles have until next Thursday to decide whether to accept the winning bid. If they do, the MLB team can begin negotiations with Iwakuma.

Friday, 11:00 PM: Patrick Newman of NPB Tracker tweets that the bidding for Japanese right-hander Hisashi Iwakuma has closed, with more than one team submitting a bid. According to MLB Trade Rumors, a report from Sports Hochi says that the Mariners are supposedly in the lead with a bid of $13 million.

Iwakuma’s team, the Tohoku Rakuten Golden Eagles, were hoping for a posting fee around $16-17 million and they reserve the right to reject the winning bid.

Many consider Ikakuma to be the second best pitcher in Japan behind Yu Darvish. The 29-year-old right-hander has a 2.82 ERA and 153/36 K/BB ratio over 201 innings this season. He earned the Pacific League MVP when he went 21-4 with a 1.87 ERA in 2008 and turned some heads stateside by posting a 1.35 ERA and 15/6 K/BB ratio over four games (three starts) in the World Baseball Classic last year.

Zach Britton receives stem cell injection, likely done for the season

Jim McIsaac/Getty Images
Leave a comment

Orioles closer Zach Britton is likely done for the remainder of the 2017 season after receiving a stem cell injection in his left knee, Peter Schmuck and Jon Meoli of the Baltimore Sun report. Britton has been battling knee problems for most of the season.

The Orioles are still technically in the AL Wild Card race, entering play Thursday 5.5 games behind the Twins for the second Wild Card slot. With only nine games remaining, however, the 73-80 Orioles are likely being realistic about their chances and not taking any unnecessary risks with Britton.

Britton, 29, put up a 2.89 ERA with 15 saves and a 29/18 K/BB ratio in 37 1/3 innings this season. He will be eligible for arbitration for the fourth and final time this offseason.

Dodgers can clinch NL West on Friday

Getty Images
Leave a comment

The Dodgers staved off a four-game series sweep at the hands of the Phillies, winning 5-4 on Thursday afternoon at Citizens Bank Park. The win reduced their magic number in the NL West to one, meaning that a win against the Giants at home or a Diamondbacks loss to the Marlins on Friday will result in clinching the division.

Of course, the Dodgers winning and the Diamondbacks losing hasn’t exactly been a sure thing lately. The D-Backs rattled off a 13-game winning streak from August 24 through September 6. The Dodgers lost 11 games in a row from September 2-11 and were on a four-game slide before Thursday’s win.

The Dodgers will send Rich Hill to the mound to start opposite Jeff Samardzija. The Diamondbacks have Zack Greinke opposing Adam Conley.